The Board of Australian communications software specialist MNF Group (ASX:MNF) is pleased to announce it has completed the refinancing of its debt facility. The new revolving facility provides better terms, more relaxed covenants, better pricing and importantly, requires no amortisation during the life of the facility.
Advertising & Media
The latest SEEK (ASX:SEK) (OTCMKTS:SKLTY) Employment Report showed a decline of 8.9% in jobs advertised compared to April 2018. Whereas, the average advertised salary across Australia rose 4.1% year on year.
MNF Group Ltd (ASX:MNF) provides the Company's latest presentation at US Roadshow.
SEEK Limited (ASX:SEK) (OTCMKTS:SKLTY) provides the Company's latest presentation at Macquarie Conference.
SEEK Limited (ASX:SEK) (OTCMKTS:SKLTY) invests in two high growth global online education businesses: FutureLearn and Coursera.
SEEK Limited (ASX:SEK) (OTCMKTS:SKLTY) is pleased to announce that Ian Narev has been appointed to the newlycreated dual role of Group Chief Operating Officer and Asia Pacific & Americas CEO.
The Board of Australian communications software specialist MNF Group (ASX:MNF) is pleased to announce it has entered into an Asset Sale Agreement with Southern Phone Company Ltd to sell its fixed line residential broadband customer base. The transaction is expected to be completed by the end of March 2019.
Banking & Finance
- YPB Group Ltd (ASX:YPB) Update on YPB Token
- Goldfields Money Ltd (ASX:GMY) Key Operating Metrics - November 2018
- YPB Group Ltd (ASX:YPB) Non-Executive Director Appointment
Oil Gas & Energy
- Central Petroleum Limited (ASX:CTP) Palm Valley 13 Well Commenced Flowing Sales Gas
- Central Petroleum Limited (ASX:CTP) Appointment of Chief Financial Officer
- Liquefied Natural Gas Ltd (ASX:LNG) Provides Update, Will Host Investor Conference Call
- MMJ Group Holdings Ltd (ASX:MMJ) To Present at Investor Conference
- VIDEO: Ellis Martin Report: Matinas BioPharma (NYSE:MTNB) Announces a Research Collaboration with ViiV Healthcare to Evaluate Formulation of Antiviral Drug Candidates
- Anatara Lifesciences Ltd (ASX:ANR) PAC Partners Equity Research Report